Hospitalisation patterns for respiratory diseases in Australia: an ecological study Authors: Ahmed Alrajeh, Abdallah Y Naser, Yousef S Aldabayan, Jaber S Alqahtani, Abdulelah Mastour Aldhahir, Rayan A Siraj, Yousif Mohammed Elmosaad, Mahmudul Hassan Al Imam, Saeed Mardy Alghamdi, Ahmed Al Haykan Published: 2024 ABSTRACT Abstract AbstractObjectivesThe objective of this study is to examine the hospitalisation profile for respiratory diseases in Australia between 1998 and 2019.DesignAn ecological study.SettingA population study that involved all private and public hospitalisations for respiratory diseases in Australia from 1998 to 2019. Data were gathered from the National Hospital Morbidity Database.ParticipantsAll patients who were hospitalised at all private and public hospitalisations for respiratory diseases in Australia.Primary outcome measureHospitalisation rates related to respiratory diseases.ResultsA total of 8 090 021 hospital admission episodes for diseases of the respiratory system were recorded in Australia between 1998 and 2019. Hospital admission rates increased by 12.4%, from 1766.45 (95% CI 1760.50 to 1772.41) in 1998 to 1985.86 (95% CI 1980.43 to 1991.28) in 2019 per 100 000 persons, p<0.05. Patients who were admitted for an overnight stay made up 82.2% of the total admissions. Females showed a greater increase in hospital admission rates (18.4%) compared with males (7.0%). The age group 15–59 years accounted for 31.0% of the total admissions. The most frequent respiratory system hospital admissions were for chronic lower respiratory diseases; these accounted for 27.8% of all admissions.ConclusionHospital admissions due to diseases of the respiratory system increased significantly in the last two decades in Australia. Male gender and younger age groups were more likely to be hospitalised for respiratory diseases. Strong public health measures are crucial to raising awareness about diseases of the respiratory system and their implications.Keywords: Hospitalization, Hospitals, EPIDEMIOLOGIC STUDIES, EPIDEMIOLOGY Strengths and limitations of this study This study investigated the hospitalisation patterns associated with all respiratory diseases in Australia in all private and public hospitals, stratified by age and gender. This study investigated the hospitalisation patterns associated with all respiratory diseases in Australia in all private and public hospitals, stratified by age and gender. Conducting ecological studies related to respiratory disease hospitalisation patterns is important in identifying research questions that warrant further investigation and research. Conducting ecological studies related to respiratory disease hospitalisation patterns is important in identifying research questions that warrant further investigation and research. The use of population-level aggregated data might overestimate or underestimate the hospitalisation rates presented. The use of population-level aggregated data might overestimate or underestimate the hospitalisation rates presented. The use of population-level aggregated data precluded our ability to conduct follow-up assessments or identify significant confounding variables. The use of population-level aggregated data precluded our ability to conduct follow-up assessments or identify significant confounding variables. Introduction Poor air quality and contemporary living are causes of respiratory diseases, which are typically chronic.1 When the pleural cavity, pleura, bronchi, alveoli, bronchioles, trachea and the breathing muscles and nerves are disrupted, breathing diseases commonly affect humans.2 Acute asthma, lung cancer, pulmonary embolism, bacterial pneumonia and the common cold are all examples of significant respiratory diseases that can fluctuate in severity.3 The WHO reports that respiratory diseases accounted for three of the top 10 causes of death in 2019 and caused more than 8 million deaths annually, with lung, bronchial and tracheal cancer at number 6, lower respiratory tract infections at number 4 and chronic obstructive pulmonary disease (COPD) at number 3.4 However, the impact on society is much more significant. The ‘big five’ lung conditions (lung cancer, acute lower respiratory tract infections, COPD, tuberculosis and asthma) were among the leading causes of death, disability and illness worldwide, according to the Global Impact of Respiratory Diseases report’s third edition, published in 2021.5 In Australia, chronic respiratory diseases including hay fever, asthma or chronic sinusitis affected 30% of the population (7.5 million people) in 2020–2021.6 Respiratory diseases are one of the main causes of mortality and morbidity worldwide, including in Australia.4 7 8 In Australia, respiratory diseases caused 5.5% of all deaths in 2018 (5.2% of deaths among males and 6.0% of deaths among females).7 Furthermore, interstitial lung disease, COPD and asthma accounted for 5.8%, 12% and 70%, respectively, of the mortality load from respiratory diseases in Australia in 2018.7 Chronic diseases—COPD and asthma—can be effectively managed, and this can mostly be done at the primary care level.9 As a result, an effective primary care system should be able to considerably lower the risk of acute exacerbation in patients with COPD or asthma and prevent the need to admit them to the hospital.9 High hospitalisation rates for these diseases point to problems with access to good primary care.9 To manage and prevent chronic and acute respiratory diseases, it is essential to create effective healthcare systems that can provide high-quality services to everyone at all stages of life.10 Therefore, our research aims to examine the hospitalisation profile for respiratory diseases in Australia. Methods Study design This was an ecological study that used an open-access and free secondary database and assessed the hospitalisation profile for respiratory diseases in Australia between 1998 and 2019. Data sources National Hospital Morbidity Database The National Hospitals Data Collection includes the National Hospital Morbidity Database (NHMD).11 Australia’s state and territory health authorities provide information to the NHMD, an online database.12 Sets of episode-level records from the morbidity data collection systems of patients admitted to private and public hospitals in Australia make up the data gathered at the NHMD. The data include information on the patient’s diagnoses, external causes of injury and poisoning, length of hospital stays, treatments they had and demographics. The National Minimum Data Set covers episodes of care for patients who have been admitted to hospitals from all alcohol and drug treatment institutions, independent day hospitals and private and public psychiatric and acute hospitals. We identified hospitalisation episodes associated with all respiratory disorders using the International Classification of Diseases (ICD)-10 (J00–J99). An overnight stay episode refers to any hospital admission where the patient stays for at least one night. Australian Bureau of Statistics From 1998 to 2019, mid-year population data were gathered using the Australian Bureau of Statistics. Data on the historical population between 1998 and 2016 were gathered using the historical population.13 Data on the population between 2017 and 2019 were gathered using the national, state and territorial populations.14 Study population This study collected data on all private and public hospitalisations for respiratory diseases in Australia from 1998 to 2019.15 Additionally, this study collected data for all age groups, both males and females. Statistical analysis All analyses were performed using SPSS V.27 (IBM Corp, Armonk, New York, USA). Hospitalisation rates with 95% CIs were calculated using respiratory disease episodes split by the mid-year population. We employed independent frequency data to assess the variation in hospitalisation incidence rates between 1998 and 2019 using the Pearson’s χ2 test of independence. Patient and public involvement None. Results Trends in total diseases of the respiratory system hospital admissions (based on separations) A total of 8 090 021 hospitalisations due to diseases of the respiratory system were recorded in Australia between 1998 and 2019. The total annual number of hospital admissions increased by 51.6% from 332 310 in 1998 to 503 727 in 2019, indicating an increase in hospital admission rates per 100 000 persons of 12.4% from 1766.45 (95% CI 1760.50 to 1772.41) in 1998 to 1985.86 (95% CI 1980.43 to 1991.28) in 2019 (p<0.05). Patients with respiratory system diseases who were admitted for an overnight stay made up 82.2% of the total number of admissions, while 17.8% were same-day patients. In 2019, there were 450.51 (95% CI 447.90 to 453.11) same-day hospital admissions for respiratory diseases, up by 107% from 1998s rate of 217.77 (95% CI 215.67 to 219.88) per 100 000 people. From 1998 to 2019, respiratory system diseases showed a 1.0% decline in the rate of overnight hospital admissions, from 1548.68 (95% CI 1543.10 to 1554.26) to 1532.59 (95% CI 1527.81 to 1537.37) per 100 000 people (figure 1). Rates of same-day and overnight-stay patients hospital admission for diseases of the respiratory system in Australia between 1998 and 2019. The most frequent respiratory system diseases that required hospital admissions were chronic lower respiratory diseases, which accounted for 27.8% of all admissions. Diseases of the upper respiratory tract came in second with 22.3%, followed by influenza and pneumonia with 20.9%, other acute lower respiratory infections with 10.2% and acute upper respiratory infections with 9.4% (table 1). Table 1Percentage of diseases of the respiratory system hospital admission from the total number of admissions per ICD codeICD codeDescriptionPercentage from total number of admissionsJ00–J06‘Acute upper respiratory infections (acute nasopharyngitis, common cold), acute sinusitis, acute pharyngitis, acute tonsillitis, acute laryngitis and tracheitis, acute obstructive laryngitis (croup) and epiglottitis, and acute upper respiratory infections of multiple and unspecified sites)’9.4%J09–J18‘Influenza and pneumonia (influenza due to certain identified influenza viruses, influenza due to other identified influenza virus, influenza due to unidentified influenza virus, viral pneumonia, not elsewhere classified, pneumonia due to Streptococcus pneumoniae, pneumonia due to Haemophilus influenzae, bacterial pneumonia, not elsewhere classified, pneumonia due to other infectious organisms, not elsewhere classified, pneumonia in diseases classified elsewhere and pneumonia, unspecified organism)’20.9%J20–J22‘Other acute lower respiratory infections (acute bronchitis, acute bronchiolitis and unspecified acute lower respiratory infection)’10.2%J30–J39‘Other diseases of upper respiratory tract (vasomotor and allergic rhinitis, chronic rhinitis, nasopharyngitis and pharyngitis, chronic sinusitis, nasal polyp, other and unspecified disorders of nose and nasal sinuses, chronic diseases of tonsils and adenoids, peritonsillar abscess, chronic laryngitis and laryngotracheitis, diseases of vocal cords and larynx, not elsewhere classified, and other diseases of upper respiratory tract)’22.3%J40–J47‘Chronic lower respiratory diseases (bronchitis, not specified as acute or chronic, simple and mucopurulent chronic bronchitis, unspecified chronic bronchitis, emphysema, other chronic obstructive pulmonary disease, asthma, bronchiectasis and chronic lung allograft dysfunction)’27.8%J60–J70‘Lung diseases due to external agents (coalworker’s pneumoconiosis, pneumoconiosis due to asbestos and other mineral fibres, pneumoconiosis due to dust containing silica, pneumoconiosis due to other inorganic dusts, unspecified pneumoconiosis, pneumoconiosis associated with tuberculosis, airway disease due to specific organic dust, hypersensitivity pneumonitis due to organic dust, respiratory conditions due to inhalation of chemicals, gases, fumes and vapours, pneumonitis due to solids and liquids, and respiratory conditions due to other external agents)’2.2%J80–J84‘Other respiratory diseases principally affecting the interstitium (acute respiratory distress syndrome, pulmonary oedema, pulmonary eosinophilia, not elsewhere classified and other interstitial pulmonary diseases)’1.3%J85–J86‘Suppurative and necrotic conditions of lower respiratory tract (abscess of lung and mediastinum and pyothorax)’0.3%J90–J94‘Other diseases of pleura (pleural effusion, not elsewhere classified, pleural effusion in conditions classified elsewhere, pleural plaque, pneumothorax and air leak, and other pleural conditions)’2.5%J95–J99‘Other diseases of the respiratory system(respiratory failure, not elsewhere classified, other respiratory disorders and respiratory disorders in diseases classified)’3.0%ICDInternational Classification of Diseases Percentage of diseases of the respiratory system hospital admission from the total number of admissions per ICD code ICDInternational Classification of Diseases Hospitalisation according to indication The rate of hospital admissions for respiratory diseases significantly increased during the study period, rising by 263% for lung diseases brought on by external factors. Additionally, the rates of hospital admissions for diseases of the respiratory system increased by 55.7%, 51.2%, 39.4%, 25.5%, 19.6%, 17.7% and 3.0% for suppurative and necrotic conditions of the lower respiratory tract, other acute lower respiratory infections, influenza and pneumonia, other pleura diseases, acute upper respiratory infections, other respiratory diseases primarily affecting the interstitium and other diseases of the upper respiratory tract, respectively. However, the patients with chronic lower respiratory diseases and other respiratory diseases were hospitalised less frequently, with decreases of 14.4% and 11.0%, respectively (table 2). Table 2Percentage change in the hospital admission rates for diseases of the respiratory system in Australia from 1998 to 2019DiseasesHospitalisation rate in 1998 per 100 000 persons (95% CI)Hospitalisation rate in 2019 per 100 000 persons (95% CI)Percentage change from 1998–2019‘Acute upper respiratory infections’163.18 (161.36 to 165.00)195.15 (193.43 to 196.86)19.6%‘Influenza and pneumonia’346.48 (343.83 to 349.14)482.87 (480.17 to 485.57)39.4%‘Other acute lower respiratory infections’130.75 (129.12 to 132.38)197.75 (196.02 to 199.48)51.2%‘Other diseases of upper respiratory tract’393.34 (390.51 to 396.17)405.22 (402.74 to 407.69)3.0%‘Chronic lower respiratory diseases’568.90 (565.50 to 572.30)486.95 (484.24 to 489.66)−14.4%‘Lung diseases due to external agents’17.38 (16.78 to 17.97)63.03 (62.06 to 64.01)262.7%‘Other respiratory diseases principally affecting the interstitium’23.53 (22.84 to 24.23)27.70 (27.06 to 28.35)17.7%‘Suppurative and necrotic conditions of lower respiratory tract’5.21 (4.88 to 5.54)8.11 (7.76 to 8.46)55.7%‘Other diseases of pleura’39.33 (38.43 to 40.22)49.37 (48.51 to 50.23)25.5%‘Other diseases of the respiratory system’78.36 (77.09 to 79.62)69.71 (68.68 to 70.74)−11.0% Percentage change in the hospital admission rates for diseases of the respiratory system in Australia from 1998 to 2019 Hospitalisation according to gender Males were involved in 4 248 520 hospital admission episodes or 52.5% of all respiratory system disease hospital admissions, with an average of 202 310 episodes per year. Female hospital admission rates for respiratory diseases increased by 18.4% between 1998 and 2019, from 1623.57 (95% CI 1615.52 to 1631.62) per 100 000 people to 1922.61 (95% CI 1915.08 to 1930.14). Hospital admission rates for respiratory diseases among males increased by 7.0%, from 1911.36 (95% CI 1902.58 to 1920.14) in 1998 to 2044.49 (95% CI 2036.67 to 2052.31) in 2019 per 100 000 people (figure 2). Rates of hospital admission for diseases of the respiratory system in Australia stratified by gender. Hospitalisation according to age In terms of age diversity for hospital admissions for respiratory diseases, the age group 15–59 years accounted for 31.0% of total admissions, followed by the age group under 15 years with 27.7%, the age group 75 years and above with 23.3% and the age group 60–74 years with 18.0%. The proportion of patients under the age of 15 who were admitted to the hospital for respiratory diseases declined by 9.6% from 2845.64 (95% CI 2829.20 to 2862.08) in 1998 to 2571.42 (95% CI 2557.18 to 2585.67) in 2019 per 100 000 people. The percentage of patients aged 15–59 who were admitted to the hospital for respiratory diseases increased by 14.3% from 871.92 (95% CI 866.62 to 877.23) in 1998 to 996.34 (95% CI 991.34 to 1001.33) in 2019 per 100 000 people. The proportion of patients aged 60–74 years who were admitted to the hospital for respiratory diseases declined by 2.7% from 2804.65 (95% CI 2782.13 to 2827.17) in 1998 to 2727.89 (95% CI 2711.24 to 2744.54) in 2019 per 100 000 people. Patients 75 years and older experienced a 26.2% increase in hospital admission rates for respiratory diseases from 5845.57 (95% CI 5800.08 to 5891.06) in 1998 to 7375.42 (95% CI 7336.75 to 7414.10) in 2019 per 100 000 people (figure 3). Rates of hospital admission for diseases of the respiratory system in Australia stratified by age group. Trends in total diseases of the respiratory system hospital admissions (based on subage group and gender) The age group below 15 years Hospital admission rates for respiratory diseases among patients aged 0–4 years, 5–9 years and 10–14 years decreased by respective amounts of 4.2%, 19.7% and 24.5% over the study period. Male patients aged 0–4 years, 5–9 years and 10–14 years experienced declines in hospital admission rates for respiratory diseases of 6.3%, 18.2% and 19.5%, respectively. Female patients with respiratory diseases were less likely to be admitted to hospitals when they were 0–4 years, 5–9 years and 10–14 years. The age group 15–59 years The rates of hospital admissions for respiratory diseases among patients aged 15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50–54 and 55–59 rose over the study period by 5.5%, 8.1%, 0.8%, 8.1%, 22.5%, 30.1%, 25.5%, 14.9% and 6.5%, respectively. Male patients’ hospital admission rates for respiratory diseases increased by 7.0%, 3.3%, 17.4%, 23.6%, 24.3%, 11.9% and 1.8% for the ages of 15–19, 30–34, 35–39, 40–44, 45–49, 50–54 and 55–59, respectively. Male patients between the ages of 20–24 and 25–29 saw a decline of 2.2% and 3.8% in hospital admission rates for respiratory diseases, respectively. Hospital admission rates for respiratory diseases among female patients aged 15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50–54 and 55–59 years increased by 4.5%, 17.3%, 4.7%, 12.5%, 27.5%, 36.5%, 26.4%, 17.7% and 10.9%, respectively. The age group 60–74 years Over the study period, the rates of patients with respiratory system diseases admitted to hospitals were lower for those in the 65–69 and 70–74 age groups by 3.7% and 1.9%, respectively. Hospital admission rates for respiratory diseases rose by 0.2% among individuals in the 60–64 age group. Male patients with respiratory diseases were less likely to be admitted to the hospital when they were 60–64 years, 65–69 years and 70–74 years. Female patients aged 60–64, 65–69 and 70–74 experienced increases in hospital admission rates for respiratory diseases by 10.6%, 9.9% and 17.5%, respectively. The age group 75 years and over The rates of hospital admissions for diseases of the respiratory system among individuals aged 75–79 years, 80–84 years and 85 years and older increased by 6.1%, 14.3% and 48.5%, respectively, over the study period. Male hospital admissions for respiratory diseases declined by 9.5% and 0.9%, respectively, among patients aged 75–79 and 80–84. Male patients 85 years and older saw a rise of 23.7% in hospital admission rates for respiratory diseases. The hospital admission rate for respiratory diseases among female patients aged 75–79, 80–84 and 85 and over rose by 23.7%, 25.0% and 60.9%, respectively. For further details on respiratory system hospital admissions stratified by age group, subage group and gender, refer to online supplemental material. Discussion This study assessed the hospitalisation profile for respiratory diseases in Australia. Between 1998 and 2019, the total number of hospital admissions due to respiratory diseases increased sharply. Among the respiratory system diseases, chronic respiratory disease was the most common cause of hospital admissions, followed by influenza, pneumonia and lower respiratory infections. The rate of hospitalisation due to respiratory system disease was higher among males; however, the percentage of change was higher among females compared with their male counterparts. In terms of age group, the 15–59 age group had the highest rate of hospital admissions due to respiratory diseases. On the other hand, individuals who were 85 years and older observed the highest increase in hospitalisations due to respiratory diseases over time. Our study found a 52% increase in the number of hospitalisations due to respiratory diseases in Australia. The country experienced a 35.6% increase in population from 18.8 million to 25.5 million between 1998 and 2019.14 16 Therefore, the population changes cannot fully explain the high changes in hospital admissions associated with respiratory diseases. The UK experienced a 133% increase in respiratory disease-induced hospitalisations, which is higher compared with our rate.17 Like other developed countries, the population of Australia is ageing as a result of sustained low fertility and increasing life expectancy, which has resulted in a larger proportion of people aged 65 and over.18 Ageing is reported to be related to changes in lung function and structure and waning immunity, which eventually increases the risk for respiratory diseases.19 Our findings also pointed out that people aged over 85 years have the highest rate of hospitalisations due to respiratory disease. This aligned with the findings of a previous study in Brazil, which reported that the age group above 80 years showed the highest hospitalisation rate for respiratory diseases (4033/100 000 persons).20 Similar to our findings, the older age group has been found more likely to be hospitalised due to respiratory diseases in the UK.17 21 22 The prevalence of respiratory disease is two to three times higher in the elderly.23 Vaccination programmes are highly effective in preventing respiratory infections and their associated hospital admissions.24 The hospitalisation rate from respiratory diseases was slightly higher among males in our study. However, the increase in hospitalisation rates was substantially higher in females than males. This finding was consistent with the findings of a previous study in Brazil, where 50.7% of hospital episodes were for males.20 The higher likelihood of hospital admissions among females could be explained partially by their higher life expectancy. Life expectancy in Australia in 2019 was 81.3 years for males and 85.4 years for females,24 while in 1998, it was 75.9 years for males and 81.5 years for females.25 Pinkerton et al argued that females are more prone to respiratory diseases because of the socio-occupational disparities between males and females.26 Earlier studies also stated that females with COPD experience higher rates of exacerbation than males.27 In terms of disease categories, chronic respiratory disease (eg, chronic lower respiratory diseases and COPD) was the most common cause of hospital admissions, followed by influenza, pneumonia and lower respiratory infections in our study. A previous study in Brazil reported that pneumonia was the main cause of hospitalisation between 2008 and 2021.20 This was followed by other COPDs (including bronchitis and emphysema), other diseases of the respiratory system and asthma.20 COPD has been reported to be the leading cause of preventable hospitalisations in Australia.28 With 7113 deaths in 2018, COPD was ranked as the fifth-leading cause of mortality in the country.29 The Australian health system spent an estimated US$977 million, representing 24% of disease expenditure on respiratory system conditions and 0.8% of total disease expenditure to manage COPD in 2015–2016.30 Similar to our findings, COPD, including asthma, and bronchiectasis were the leading cause of hospital admissions due to respiratory diseases in the UK.17 21 Early diagnosis and early intervention to prevent acute exacerbation and delay the progression of diseases were among the top 10 research priorities recommended in joint patient–clinician research prioritising ventures for exacerbation of COPD.31,34 Smoking is a key contributor to respiratory diseases and their associated morbidity and mortality globally. Although the smoking rate showed a downward trend in Australia from 24% to 11% between 1991 and 2019,35 this could be considered a predictor of hospital admissions due to respiratory disease. Naser et al argued that the chronic effect of nicotine can have long-term consequences even after quitting smoking.17 Tran et al found that smoking is associated with an increased risk of preventable hospitalisation for chronic conditions in older adults, and smoking cessation, even at older ages, reduces this risk.36 Policy-makers should devise strategies to reduce the smoking rate to prevent hospitalisations associated with respiratory diseases. Like most studies, this study inherited some limitations. Hence, readers should interpret the results of this study with caution. This study used a secondary database, which might be affected by data accuracy, completeness and standardisation. The factors presented in this study are based on the average of the population data and without any statistical tests having been performed to determine association. Also, the disease coding, diagnosis and completeness of reporting in Australia might be different from other countries. Therefore, the comparison presented in this study might not be a true reflection of the countries compared. Additionally, this study could not identify confounding factors due to a lack of individual-level data. Despite these limitations, this study has clinical and research implications. The findings of the study will guide public health professionals in taking necessary measures to control respiratory diseases including, but not limited to, increasing awareness about the risk factors, causes and burden of respiratory diseases and implementing adequate infection control measures. This study will also underscore the importance of allocating resources for early diagnosis of and early intervention in chronic respiratory diseases. Future studies should focus on the development of therapies that could prevent disease progression, exacerbation and hospital admissions from chronic respiratory diseases. Conclusion This study found that hospital admissions due to diseases of the respiratory system increased by 52% in Australia in the last two decades. Males and younger age groups were more likely to be hospitalised from respiratory diseases. Strong public health measures are crucial to raising awareness about diseases of the respiratory system and their implications. Empirical studies on respiratory diseases are required to enable early diagnosis, early intervention and prevention of disease progression and hospital admissions. supplementary material Footnotes Funding: The authors extend their appreciation to the Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia for funding this research work through the project number (Grant No: INST117). prepub: Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2024-084286). Provenance and peer review: Not commissioned; externally peer reviewed. Patient consent for publication: Not applicable. Data availability free text: Publicly available datasets were analysed in this study. These data can be found here https://meteor.aihw.gov.au/content/394352. Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research. Ethics approval: This study used deidentified and aggregated data and was considered exempt from human protection oversight by the institutional review board at Isra University, Amman, Jordan. Studies that are based on secondary databases, such as the NHMD, do not require ethics approval to research. The NHMRC guidelines further state that research conducted using publicly available data derived from non-identifiable subjects is exempt from ethics review. This study was conducted in accordance with the World Medical Association (WMA) Declaration of Helsinki. Contributor Information Ahmed Alrajeh, Email: amalrajeh@kfu.edu.sa. Abdallah Y Naser, Email: abdallah.naser@iu.edu.jo. Yousef S Aldabayan, Email: yaldabayan@kfu.edu.sa. Jaber S Alqahtani, Email: Alqahtani-Jaber@hotmail.com. Abdulelah Mastour Aldhahir, Email: aldhahir.abdulelah@hotmail.com. Rayan A Siraj, Email: rsiraj@kfu.edu.sa. Yousif Mohammed Elmosaad, Email: yelmosaad@kfu.edu.sa. Mahmudul Hassan Al Imam, Email: physiomahmud@yahoo.com. Saeed Mardy Alghamdi, Email: smghamdi@uqu.edu.sa. Ahmed Al Haykan, Email: aalhaykan@kfu.edu.sa. Data availability statement Data are available in a public, open access repository. References Supplementary Materials Data Availability Statement Data are available in a public, open access repository.